Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Cost of Revenue (2021 - 2025)

Historic Cost of Revenue for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to $1008.0.

  • HeartSciences' Cost of Revenue fell 9896.17% to $1008.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $197940.0, marking a year-over-year decrease of 139.14%. This contributed to the annual value of $1880.0 for FY2025, which is 6908.4% down from last year.
  • Latest data reveals that HeartSciences reported Cost of Revenue of $1008.0 as of Q4 2025, which was down 9896.17% from $760.0 recorded in Q3 2025.
  • Over the past 5 years, HeartSciences' Cost of Revenue peaked at $99091.0 during Q3 2024, and registered a low of $760.0 during Q1 2023.
  • For the 5-year period, HeartSciences' Cost of Revenue averaged around $19518.8, with its median value being $1520.0 (2023).
  • Per our database at Business Quant, HeartSciences' Cost of Revenue surged by 628690.79% in 2024 and then crashed by 9923.3% in 2025.
  • Over the past 5 years, HeartSciences' Cost of Revenue (Quarter) stood at $5756.0 in 2021, then plummeted by 64.63% to $2036.0 in 2022, then decreased by 25.34% to $1520.0 in 2023, then skyrocketed by 6286.91% to $97081.0 in 2024, then tumbled by 98.96% to $1008.0 in 2025.
  • Its last three reported values are $1008.0 in Q4 2025, $760.0 for Q3 2025, and $97081.0 during Q4 2024.